compounding glp-1 enforcement news Out of Shortage, Into Controversy: The Fight Over FDA to Restrict Ingredients Used

| 10 comments on LinkedIn

Discover how natural fibers can support appetite control and blood sugar regulation by boosting gut hormones, offering a food-first approach to metabolic health without medication.

Key players in Chiles GLP-1 segment: Novo Nordisk Market leader with Ozempic, Victoza, and Wegovy Eli Lilly Bringing innovation with Mounjaro (Tirzepatide) Sanofi Providing Soliqua, a GLP-1 + insulin combo CFR Pharmaceuticals (Abbott) Local affiliate with strong market access Biocon Expanding biosimilar reach in Latam AstraZeneca Strategic focus on metabolic & cardiovascular synergy With increasing physician adoption and patient demand, Chile is evolving into a high-opportunity market for obesity and type 2 diabetes therapies

Pharmaceutical companies marketing or developing anti-obesity medications can never hope to fully control the obesity Social Media narrative

I'll show you how to order smart and enjoy your favorite fast food guilt-free perfect for weight loss goals!